SCHEMBL19620550

SCHEMBL19620550

NC1=C(OSCc2ccccc2)C(=O)C(c2ccccn2)O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
MDM2 Q00987 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 3/20 0.38
ADORA2A P29274 1/20 0.37
HSD17B10 Q99714 2/20 0.33
POLB P06746 1/20 0.33
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ALOX15 P16050 1/20 0.32
DAO P14920 1/20 0.32
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620603 0.82 POLB (0.50) KMT2AMAPTKDM4ENPC1RAB9A
SCHEMBL19620533 0.82 MAPT (0.42) MAPTKDM4ENPC1RAB9AALDH1A1
SCHEMBL19620561 0.81 SMN1; SMN2 (0.34) MAPTKDM4EALDH1A1POLBSMN1; SMN2
SCHEMBL19620559 0.81 ALDH1A1 (0.41) KMT2AMAPTKDM4EMEN1NPC1
SCHEMBL19620650 0.80 CYP19A1 (0.42) MAPTKDM4EMDM2NPC1RAB9A
SCHEMBL19620504 0.79 TP53 (0.43) KMT2AMAPTKDM4EMEN1NPC1
SCHEMBL15627563 0.78 KMT2A (0.40) KMT2AMAPTKDM4EMEN1MDM2
SCHEMBL19620557 0.78 KMT2A (0.40) KMT2AMAPTKDM4EMEN1MDM2
SCHEMBL29851977 0.78 KMT2A (0.40) KMT2AMAPTKDM4EMEN1MDM2
SCHEMBL19620675 0.77 MAPT (0.42) KMT2AMAPTKDM4EMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed